1. wallburscha
2. nikkibb51097
3. blueauger497
4. dmen5261
1.blueauger497 09/13/2018
Natera Signs Agreement with Bristol-Myers Squibb to Investigate Signatera™ ctDNA Assay as a Potential Biomarker for Opdivo (nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clin
2.blueauger497 03/12/2018
Qiagen and Natera announced a partnership to develop cell-free DNA assays for use on QIAGEN’s GeneReader N…
3.wallburscha 03/14/2018
Natera Reports Fourth Quarter and Fiscal Year 2017 Financial Results
4.dmen5261 06/21/2018
Natera Develops Powerful Kidney Transplant Rejection Biomarker
5.wallburscha 04/13/2018
Company will present data on Signatera in bladder and colorectal cancers at the AACR
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW